Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, 6-Month Evaluation of the Safety and Efficacy of Topical Alprostadil in Hysterectomized Women With Female Sexual Arousal Disorder (FSAD)

NCT00324948 is registered in ClinicalTrials.gov with VIVUS LLC as lead sponsor.

NCT NCT00324948
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00324948 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, 6-Month Evaluation of the Safety and Efficacy of Topical Alprostadil in Hysterectomized Women With Female Sexual Arousal Disorder (FSAD)
Lead sponsor
VIVUS LLC
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2004
Completion date
November 30, 2006
Enrollment
300
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sexual dysfunction, physiological